XTAE
TUZA
Market cap16mUSD
Apr 29, Last price
42.20ILS
Name
Teuza A Fairchild Technology Venture Ltd
Chart & Performance
P/E
—
P/S
61.71
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
121.40%
Revenues
266k
-88.80%
Net income
-2m
L-69.40%
CFO
-1m
L-26.18%
Dividend
Nov 17, 20152.4188 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Teuza - A Fairchild Technology Venture Ltd. primarily focuses on providing growth equity and hybrid debt-equity financing solutions. Its investment mandate spans a wide range of company maturities, from nascent seed and startup phases through early, mid, and late-stage ventures, extending to established middle-market enterprises. The firm actively seeks opportunities across various technology-driven sectors, including semiconductors, enterprise software, general IT software, healthcare, electronics, medical devices, biotechnology, and both telecommunications and broader communications industries. Geographically, Teuza prioritizes investments in companies located in Israel, China, Canada, and the United States. Individual investments typically fall within the range of $1 million to $2 million. Furthermore, Teuza generally acquires an equity stake ranging from 25% to 49% in its portfolio firms, often securing a seat on their Board of Directors. The firm's strategy for exiting these investments primarily involves either an Initial Public Offering (IPO) or a Merger and Acquisition (M&A) deal.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||